Selected research
Market Outlook & Growth Opportunities
Global Supplement Contract Manufacturing Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Supplement Contract Manufacturing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Supplement Contract Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Supplement Contract Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Supplement Contract Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Supplement Contract Manufacturing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Supplement Contract Manufacturing Services market include Martinez Nieto, Lonza Group, Aenova, SALUS Haus, Gemini Pharmaceuticals, MediGrUn Naturprodukte, Goerlich Pharma GmbH, Sanomed and Biovencer Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Supplement Contract Manufacturing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Supplement Contract Manufacturing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Supplement Contract Manufacturing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Supplement Contract Manufacturing Services market.
Supplement Contract Manufacturing Services Segment by Company
Martinez Nieto
Lonza Group
Aenova
SALUS Haus
Gemini Pharmaceuticals
MediGrUn Naturprodukte
Goerlich Pharma GmbH
Sanomed
Biovencer Healthcare
CAPTEK Softgel International
Divine Design Manufacturing
PlantaCorp
Hendel
Biotrex Nutraceuticals
HKS Health Solutions
NutraScience Labs
NextPharma
Sirio Pharma
Soft Gel Technologies
Celmark
TCI Group
Robinson Pharma
Trividia Manufacturing Solutions
Rain Nutrience
Pharmatech Labs
Matsun Nutrition
NutraLab Canada
Supplement Contract Manufacturing Services Segment by Type
Tablets
Capsules
Gummies
Liquid
Others
Supplement Contract Manufacturing Services Segment by Application
Protein and Amino Acid
Multivitamin
Weight Management Supplements
Others
Supplement Contract Manufacturing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Supplement Contract Manufacturing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Supplement Contract Manufacturing Services key companies, revenue, market share, and recent developments.
3. To split the Supplement Contract Manufacturing Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Supplement Contract Manufacturing Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Supplement Contract Manufacturing Services significant trends, drivers, influence factors in global and regions.
6. To analyze Supplement Contract Manufacturing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Supplement Contract Manufacturing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Supplement Contract Manufacturing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Supplement Contract Manufacturing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Supplement Contract Manufacturing Services industry.
Chapter 3: Detailed analysis of Supplement Contract Manufacturing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Supplement Contract Manufacturing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Supplement Contract Manufacturing Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
- Gummies
- Liquid
- Others
Applications
- Protein and Amino Acid
- Multivitamin
- Weight Management Supplements
- Others
Companies covered
- Martinez Nieto
- Lonza Group
- Aenova
- SALUS Haus
- Gemini Pharmaceuticals
- MediGrUn Naturprodukte
- Goerlich Pharma GmbH
- Sanomed
- Biovencer Healthcare
- CAPTEK Softgel International
- Divine Design Manufacturing
- PlantaCorp
- Hendel
- Biotrex Nutraceuticals
- HKS Health Solutions
- NutraScience Labs
- NextPharma
- Sirio Pharma
- Soft Gel Technologies
- Celmark
- TCI Group
- Robinson Pharma
- Trividia Manufacturing Solutions
- Rain Nutrience
- Pharmatech Labs
- Matsun Nutrition
- NutraLab Canada
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Supplement Contract Manufacturing Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Supplement Contract Manufacturing Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Supplement Contract Manufacturing Services Market Dynamics
- 2.1 Supplement Contract Manufacturing Services Industry Trends
- 2.2 Supplement Contract Manufacturing Services Industry Drivers
- 2.3 Supplement Contract Manufacturing Services Industry Opportunities and Challenges
- 2.4 Supplement Contract Manufacturing Services Industry Restraints
3 Supplement Contract Manufacturing Services Market by Company
- 3.1 Global Supplement Contract Manufacturing Services Company Revenue Ranking in 2025
- 3.2 Global Supplement Contract Manufacturing Services Revenue by Company (2021-2026)
- 3.3 Global Supplement Contract Manufacturing Services Company Ranking (2024-2026)
- 3.4 Global Supplement Contract Manufacturing Services Company Manufacturing Base and Headquarters
- 3.5 Global Supplement Contract Manufacturing Services Company Product Type and Application
- 3.6 Global Supplement Contract Manufacturing Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Supplement Contract Manufacturing Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Supplement Contract Manufacturing Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Supplement Contract Manufacturing Services Market by Type
- 4.1 Supplement Contract Manufacturing Services Type Introduction
- 4.1.1 Tablets
- 4.1.2 Capsules
- 4.1.3 Gummies
- 4.1.4 Liquid
- 4.1.5 Others
- 4.2 Global Supplement Contract Manufacturing Services Sales Value by Type
- 4.2.1 Global Supplement Contract Manufacturing Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Supplement Contract Manufacturing Services Sales Value by Type (2021-2032)
- 4.2.3 Global Supplement Contract Manufacturing Services Sales Value Share by Type (2021-2032)
5 Supplement Contract Manufacturing Services Market by Application
- 5.1 Supplement Contract Manufacturing Services Application Introduction
- 5.1.1 Protein and Amino Acid
- 5.1.2 Multivitamin
- 5.1.3 Weight Management Supplements
- 5.1.4 Others
- 5.2 Global Supplement Contract Manufacturing Services Sales Value by Application
- 5.2.1 Global Supplement Contract Manufacturing Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Supplement Contract Manufacturing Services Sales Value by Application (2021-2032)
- 5.2.3 Global Supplement Contract Manufacturing Services Sales Value Share by Application (2021-2032)
6 Supplement Contract Manufacturing Services Regional Value Analysis
- 6.1 Global Supplement Contract Manufacturing Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Supplement Contract Manufacturing Services Sales Value by Region (2021-2032)
- 6.2.1 Global Supplement Contract Manufacturing Services Sales Value by Region: 2021-2026
- 6.2.2 Global Supplement Contract Manufacturing Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Supplement Contract Manufacturing Services Sales Value (2021-2032)
- 6.3.2 North America Supplement Contract Manufacturing Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Supplement Contract Manufacturing Services Sales Value (2021-2032)
- 6.4.2 Europe Supplement Contract Manufacturing Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Supplement Contract Manufacturing Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Supplement Contract Manufacturing Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Supplement Contract Manufacturing Services Sales Value (2021-2032)
- 6.6.2 South America Supplement Contract Manufacturing Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Supplement Contract Manufacturing Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Supplement Contract Manufacturing Services Sales Value Share by Country, 2025 VS 2032
7 Supplement Contract Manufacturing Services Country-level Value Analysis
- 7.1 Global Supplement Contract Manufacturing Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Supplement Contract Manufacturing Services Sales Value by Country (2021-2032)
- 7.2.1 Global Supplement Contract Manufacturing Services Sales Value by Country (2021-2026)
- 7.2.2 Global Supplement Contract Manufacturing Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Supplement Contract Manufacturing Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Supplement Contract Manufacturing Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Supplement Contract Manufacturing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Martinez Nieto
- 8.1.1 Martinez Nieto Company Information
- 8.1.2 Martinez Nieto Business Overview
- 8.1.3 Martinez Nieto Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Martinez Nieto Supplement Contract Manufacturing Services Product Portfolio
- 8.1.5 Martinez Nieto Recent Developments
- 8.2 Lonza Group
- 8.2.1 Lonza Group Company Information
- 8.2.2 Lonza Group Business Overview
- 8.2.3 Lonza Group Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Lonza Group Supplement Contract Manufacturing Services Product Portfolio
- 8.2.5 Lonza Group Recent Developments
- 8.3 Aenova
- 8.3.1 Aenova Company Information
- 8.3.2 Aenova Business Overview
- 8.3.3 Aenova Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Aenova Supplement Contract Manufacturing Services Product Portfolio
- 8.3.5 Aenova Recent Developments
- 8.4 SALUS Haus
- 8.4.1 SALUS Haus Company Information
- 8.4.2 SALUS Haus Business Overview
- 8.4.3 SALUS Haus Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.4.4 SALUS Haus Supplement Contract Manufacturing Services Product Portfolio
- 8.4.5 SALUS Haus Recent Developments
- 8.5 Gemini Pharmaceuticals
- 8.5.1 Gemini Pharmaceuticals Company Information
- 8.5.2 Gemini Pharmaceuticals Business Overview
- 8.5.3 Gemini Pharmaceuticals Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Gemini Pharmaceuticals Supplement Contract Manufacturing Services Product Portfolio
- 8.5.5 Gemini Pharmaceuticals Recent Developments
- 8.6 MediGrUn Naturprodukte
- 8.6.1 MediGrUn Naturprodukte Company Information
- 8.6.2 MediGrUn Naturprodukte Business Overview
- 8.6.3 MediGrUn Naturprodukte Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.6.4 MediGrUn Naturprodukte Supplement Contract Manufacturing Services Product Portfolio
- 8.6.5 MediGrUn Naturprodukte Recent Developments
- 8.7 Goerlich Pharma GmbH
- 8.7.1 Goerlich Pharma GmbH Company Information
- 8.7.2 Goerlich Pharma GmbH Business Overview
- 8.7.3 Goerlich Pharma GmbH Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Goerlich Pharma GmbH Supplement Contract Manufacturing Services Product Portfolio
- 8.7.5 Goerlich Pharma GmbH Recent Developments
- 8.8 Sanomed
- 8.8.1 Sanomed Company Information
- 8.8.2 Sanomed Business Overview
- 8.8.3 Sanomed Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Sanomed Supplement Contract Manufacturing Services Product Portfolio
- 8.8.5 Sanomed Recent Developments
- 8.9 Biovencer Healthcare
- 8.9.1 Biovencer Healthcare Company Information
- 8.9.2 Biovencer Healthcare Business Overview
- 8.9.3 Biovencer Healthcare Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Biovencer Healthcare Supplement Contract Manufacturing Services Product Portfolio
- 8.9.5 Biovencer Healthcare Recent Developments
- 8.10 CAPTEK Softgel International
- 8.10.1 CAPTEK Softgel International Company Information
- 8.10.2 CAPTEK Softgel International Business Overview
- 8.10.3 CAPTEK Softgel International Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.10.4 CAPTEK Softgel International Supplement Contract Manufacturing Services Product Portfolio
- 8.10.5 CAPTEK Softgel International Recent Developments
- 8.11 Divine Design Manufacturing
- 8.11.1 Divine Design Manufacturing Company Information
- 8.11.2 Divine Design Manufacturing Business Overview
- 8.11.3 Divine Design Manufacturing Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Divine Design Manufacturing Supplement Contract Manufacturing Services Product Portfolio
- 8.11.5 Divine Design Manufacturing Recent Developments
- 8.12 PlantaCorp
- 8.12.1 PlantaCorp Company Information
- 8.12.2 PlantaCorp Business Overview
- 8.12.3 PlantaCorp Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.12.4 PlantaCorp Supplement Contract Manufacturing Services Product Portfolio
- 8.12.5 PlantaCorp Recent Developments
- 8.13 Hendel
- 8.13.1 Hendel Company Information
- 8.13.2 Hendel Business Overview
- 8.13.3 Hendel Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Hendel Supplement Contract Manufacturing Services Product Portfolio
- 8.13.5 Hendel Recent Developments
- 8.14 Biotrex Nutraceuticals
- 8.14.1 Biotrex Nutraceuticals Company Information
- 8.14.2 Biotrex Nutraceuticals Business Overview
- 8.14.3 Biotrex Nutraceuticals Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Biotrex Nutraceuticals Supplement Contract Manufacturing Services Product Portfolio
- 8.14.5 Biotrex Nutraceuticals Recent Developments
- 8.15 HKS Health Solutions
- 8.15.1 HKS Health Solutions Company Information
- 8.15.2 HKS Health Solutions Business Overview
- 8.15.3 HKS Health Solutions Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.15.4 HKS Health Solutions Supplement Contract Manufacturing Services Product Portfolio
- 8.15.5 HKS Health Solutions Recent Developments
- 8.16 NutraScience Labs
- 8.16.1 NutraScience Labs Company Information
- 8.16.2 NutraScience Labs Business Overview
- 8.16.3 NutraScience Labs Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.16.4 NutraScience Labs Supplement Contract Manufacturing Services Product Portfolio
- 8.16.5 NutraScience Labs Recent Developments
- 8.17 NextPharma
- 8.17.1 NextPharma Company Information
- 8.17.2 NextPharma Business Overview
- 8.17.3 NextPharma Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.17.4 NextPharma Supplement Contract Manufacturing Services Product Portfolio
- 8.17.5 NextPharma Recent Developments
- 8.18 Sirio Pharma
- 8.18.1 Sirio Pharma Company Information
- 8.18.2 Sirio Pharma Business Overview
- 8.18.3 Sirio Pharma Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.18.4 Sirio Pharma Supplement Contract Manufacturing Services Product Portfolio
- 8.18.5 Sirio Pharma Recent Developments
- 8.19 Soft Gel Technologies
- 8.19.1 Soft Gel Technologies Company Information
- 8.19.2 Soft Gel Technologies Business Overview
- 8.19.3 Soft Gel Technologies Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.19.4 Soft Gel Technologies Supplement Contract Manufacturing Services Product Portfolio
- 8.19.5 Soft Gel Technologies Recent Developments
- 8.20 Celmark
- 8.20.1 Celmark Company Information
- 8.20.2 Celmark Business Overview
- 8.20.3 Celmark Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.20.4 Celmark Supplement Contract Manufacturing Services Product Portfolio
- 8.20.5 Celmark Recent Developments
- 8.21 TCI Group
- 8.21.1 TCI Group Company Information
- 8.21.2 TCI Group Business Overview
- 8.21.3 TCI Group Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.21.4 TCI Group Supplement Contract Manufacturing Services Product Portfolio
- 8.21.5 TCI Group Recent Developments
- 8.22 Robinson Pharma
- 8.22.1 Robinson Pharma Company Information
- 8.22.2 Robinson Pharma Business Overview
- 8.22.3 Robinson Pharma Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.22.4 Robinson Pharma Supplement Contract Manufacturing Services Product Portfolio
- 8.22.5 Robinson Pharma Recent Developments
- 8.23 Trividia Manufacturing Solutions
- 8.23.1 Trividia Manufacturing Solutions Company Information
- 8.23.2 Trividia Manufacturing Solutions Business Overview
- 8.23.3 Trividia Manufacturing Solutions Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.23.4 Trividia Manufacturing Solutions Supplement Contract Manufacturing Services Product Portfolio
- 8.23.5 Trividia Manufacturing Solutions Recent Developments
- 8.24 Rain Nutrience
- 8.24.1 Rain Nutrience Company Information
- 8.24.2 Rain Nutrience Business Overview
- 8.24.3 Rain Nutrience Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.24.4 Rain Nutrience Supplement Contract Manufacturing Services Product Portfolio
- 8.24.5 Rain Nutrience Recent Developments
- 8.25 Pharmatech Labs
- 8.25.1 Pharmatech Labs Company Information
- 8.25.2 Pharmatech Labs Business Overview
- 8.25.3 Pharmatech Labs Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.25.4 Pharmatech Labs Supplement Contract Manufacturing Services Product Portfolio
- 8.25.5 Pharmatech Labs Recent Developments
- 8.26 Matsun Nutrition
- 8.26.1 Matsun Nutrition Company Information
- 8.26.2 Matsun Nutrition Business Overview
- 8.26.3 Matsun Nutrition Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.26.4 Matsun Nutrition Supplement Contract Manufacturing Services Product Portfolio
- 8.26.5 Matsun Nutrition Recent Developments
- 8.27 NutraLab Canada
- 8.27.1 NutraLab Canada Company Information
- 8.27.2 NutraLab Canada Business Overview
- 8.27.3 NutraLab Canada Supplement Contract Manufacturing Services Revenue and Gross Margin (2021-2026)
- 8.27.4 NutraLab Canada Supplement Contract Manufacturing Services Product Portfolio
- 8.27.5 NutraLab Canada Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst